Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Engineering of a Potent, Long-Acting NPY2R Agonist for Combination with a GLP-1R Agonist as a Multi-Hormonal Treatment for Obesity
Sam Lear, Elsa Pflimlin, Zhihong Zhou, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 17, pp. 9660-9671
Closed Access | Times Cited: 19

Showing 19 citing articles:

Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease
Laurie L. Baggio, Daniel J. Drucker
Molecular Metabolism (2020) Vol. 46, pp. 101090-101090
Open Access | Times Cited: 219
Derivatization with fatty acids in peptide and protein drug discovery
Peter Kurtzhals, Søren Østergaard, Erica Nishimura, et al.
Nature Reviews Drug Discovery (2022) Vol. 22, Iss. 1, pp. 59-80
Closed Access | Times Cited: 69
The effect of fatty diacid acylation of human PYY3-36 on Y2 receptor potency and half-life in minipigs
Søren Østergaard, Johan F. Paulsson, Jacob Kofoed, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 34
Evolution of peptide YY analogs for the management of type 2 diabetes and obesity
Wang Chen, Gong Binbin, Lidan Sun, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106808-106808
Closed Access | Times Cited: 14
Rational design of dual-agonist peptides targeting GLP-1 and NPY2 receptors for regulating glucose homeostasis and body weight with minimal nausea and emesis
Jing Liu, Weiwen Lu, Han Wu, et al.
European Journal of Medicinal Chemistry (2025), pp. 117320-117320
Closed Access
Conjugates for use in peptide therapeutics: A systematic review and meta-analysis
Ashan Wijesinghe, Sarika Kumari, Valerie Booth
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0255753-e0255753
Open Access | Times Cited: 18
Design of Xenopus GLP-1-Based Long-Acting Dual GLP-1/Y2 Receptor Agonists
Qimeng Yang, Weizhong Tang, Lidan Sun, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 20, pp. 14201-14220
Closed Access | Times Cited: 10
α/Sulfono-γ-AApeptide Hybrid Analogues of Glucagon with Enhanced Stability and Prolonged In Vivo Activity
Peng Sang, Hongxiang Zeng, Candy Lee, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 18, pp. 13893-13901
Open Access | Times Cited: 11
Amplifying the antidiabetic actions of glucagon‐like peptide‐1: Potential benefits of new adjunct therapies
Neil Tanday, Peter R. Flatt, Nigel Irwin
Diabetic Medicine (2021) Vol. 38, Iss. 12
Open Access | Times Cited: 9
Engineering a potent and long-acting GLP-1/Y2 receptor dual agonist as a multi-agonist therapy for diabetes and obesity
Jing Xu, Shuang Wang, Han Wu, et al.
Peptides (2023) Vol. 169, pp. 171073-171073
Closed Access | Times Cited: 3
Discovery of a potent and long-acting Xenopus GLP-1-based GLP-1/glucagon/Y2 receptor triple agonist
Yongliang Yuan, Zhiming Yan, Qifang Lao, et al.
European Journal of Medicinal Chemistry (2022) Vol. 247, pp. 115036-115036
Closed Access | Times Cited: 5
Screening of the Key Genes and Signaling Pathways for Schizophrenia Using Bioinformatics and Next Generation Sequencing Data Analysis
Basavaraj Vastrad, Chanabasayya Vastrad
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Long-Acting Tumor-Activated Prodrug of a TGFβR Inhibitor
Yong Zhang, Karen E. Parrish, David R. Tortolani, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 21, pp. 15787-15798
Closed Access | Times Cited: 4
Screening of the key genes and signaling pathways for schizophrenia using bioinformatics and next generation sequencing data analysis
Iranna Kotturshetti, Basavaraj Vastrad, Veena Kori, et al.
Italian Journal of Medicine (2024) Vol. 18, Iss. 4
Open Access
Stapled peptides as potential therapeutics for diabetes and other metabolic diseases
Dominika Nielipińska, Dominika Rubiak, Agnieszka J Pietrzyk-Brzezińska, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117496-117496
Open Access
Entrepreneurial Drug Hunter
Tomi K. Sawyer
(2022), pp. 273-292
Closed Access | Times Cited: 2
Targeting the Enteroendocrine System for Treatment of Obesity
Emily L. Miedzybrodzka, Fiona M. Gribble, Frank Reimann
Handbook of experimental pharmacology (2022), pp. 487-513
Closed Access | Times Cited: 2
Identification of differentially expressed genes and signaling pathways in gestational diabetes mellitus by integrated bioinformatics analysis
Basavaraj Vastrad, Chanabasayya Vastrad
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1
Conjugates for use in peptide therapeutics: a systematic review and meta-analysis
Ashan Wijesinghe, Sarika Kumari, Valerie Booth
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
Page 1

Scroll to top